Anyone treated with Adstiladrin for BCG-unresponsive bladder cancer?

Posted by DAVID B. @davidpball, Jul 22, 2024

Does anyone have experience with adstiladrin for treatment of BCG refractive NMIBC?

Interested in more discussions like this? Go to the Bladder Cancer Support Group.

Since my initial diagnosis and Surgery on Nov 2021, I've had 4 reoccurances of Low grade, low stage non muscle invasive bladder cancer. I was told from the start there's a 65% chance it comes back. I keep getting 3 bcg treatments every 6 months. In total I've received 21 to 24 of those. On my next cysto in Oct I'm gonna ask about this new treatment. On all of those reoccurances, they were able to remove them at the office thru the scope.

REPLY

Just had cystoscopy after having cancer scraped out of bladder and 6 BCG treatments. Cancer is back and Dr. wants to do everything again. Wondering why he thinks it will work this time if not first time. Anyone else have the BCG more than once? What is Adstiladrin? Is this a Trial or approved treatment? Success rate? Good luck to us all.

REPLY
@davidpball

Yes, I am scheduled to receive a first dose of Adstiladrin.

Jump to this post

I received a first dose of Adstiladrin on 7/26/24. Side effects during first 24 hours included fever, chills, body aches, and fatigue, which abated after 72 hours. I will schedule a blue light cystoscopy in about eight weeks to assess progress against NMIBC/CIS.

REPLY
@colleenyoung

Hi @davidpball, I expanded the title of your discussion to hopefully attract more responses. As you likely know, Adstiladrin (nadofaragene firadenovec-vncg) was recently approved for bladder cancer. It is a gene therapy currently used for adult patients with high-risk Bacillus Calmette-Guérin (BCG)-unresponsive non-muscle invasive bladder cancer (NMIBC).

David, is Adstiladrin a treatment option for you?

Jump to this post

Yes, I am scheduled to receive a first dose of Adstiladrin.

REPLY

Hi @davidpball, I expanded the title of your discussion to hopefully attract more responses. As you likely know, Adstiladrin (nadofaragene firadenovec-vncg) was recently approved for bladder cancer. It is a gene therapy currently used for adult patients with high-risk Bacillus Calmette-Guérin (BCG)-unresponsive non-muscle invasive bladder cancer (NMIBC).

David, is Adstiladrin a treatment option for you?

REPLY
Please sign in or register to post a reply.